Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'drug data'
drug data published presentations and documents on DocSlides.
Concepts in Measurement for Hospital Based Pharmacies
by luanne-stotts
Michael R McDaniel, R.Ph., MBA, FASHP. Director o...
Creating Transparent SDTM-Based Datasets
by olivia-moreira
Jerry Salyers. Senior Consultant. Richard Lewis. ...
Nordic prescription registers
by calandra-battersby
Finland. Leena K Saastamoinen. The Social Insuran...
LAC MHLA PSA Overview
by marina-yarberry
A Joint Effort with Ventegra + MHLA & DHS + C...
“Wat kunnen wij leren uit Europese projecten?”
by phoebe-click
Lessons. . from. . European. . Projects. Jos D...
Stability Studies - Evaluation of Outcomes and Development
by tatyana-admore
of . Documentation For Regulatory Submissions. Bo...
Funding opportunities
by kittie-lecroy
Background. New category of funding in the FY13 H...
Agent-based
by yoshiko-marsland
modelling. . of burglary. Andy Evans. Nick . Mal...
Nordic Prescription Registers
by pasty-toler
Iceland. Helga Zoëga. Epidemiology. Mount Sinai ...
Medsci
by phoebe-click
303. Lab 2. Potency of agonists and antagonists....
Testing the performance of the two-fold FCS algorithm for m
by trish-goza
Catherine Welch. 1. , Irene Petersen. 1. , Jonath...
CS315-Web Search and Data Mining
by karlyn-bohler
Trust and Privacy . in Anonymous Online Communiti...
Chemical Data and
by tatyana-admore
Computer-Aided Drug Discovery. Mike Gilson. Schoo...
Computational characterization of
by sherrill-nordquist
biomolecular. networks in physiology and disease...
Real World
by yoshiko-marsland
Objects and relationships. Database. Schema. (Obj...
Assignment
by celsa-spraggs
2. Don’t forget the Flickr assignment #2 (due e...
Understanding and preventing crime:
by faustina-dinatale
A new generation of simulation models. Nick Malle...
Joining
by mitsue-stanley
Private and Public Forces to Boost . Innovation i...
Thank You For Joining Us!
by giovanna-bartolotta
During the webinar . p. lease . mute your line us...
Chapter 7 Using AI to Address Medical Needs
by kieran147
Monitoring patients more effectively. Assisting hu...
Session Research Stages Conducting Clinical Trial Todays
by king142
SESSION 8. Handout/Reference sheets:. Study Start-...
S trategy for I mproving
by apollo233
S. troke . T. reatment . R. esponse . Imaging Mana...
Drug Utilization Study - First line treatment with conventional synthetic Disease Modifying Antirhe
by jesiah
Anthony Sena. Objectives. Characterize treatment p...
CERTIFICATION EXAM PREPARATION COURSE
by ezrah
SESSION 8. Handout/Reference sheets:. Study Start-...
July 2015 PRABHAVATHI FERNANDES, PhD
by fauna
Founder, President and CEO. How the PATH Act Can R...
ADPC Statewide Strategic Plan Overview
by gagnon
Tori Algee. ADPC Senior Policy Analyst. Will Burch...
Pharmacometrics and Biostatistics Interactions at the FDA
by byrne
Jeffry Florian, Ph.D.. Division of Pharmacometrics...
1 An Introduction to Bioinformatics
by bery
and its application in . Protein-DNA/Protein Int...
Internship at Inclin Kelly Speth
by margaret
November 4, 2013. My Background & Experience. ...
1 Evaluating & Applying What Works Best
by patricia
Leaders’ Project. . Policy Forum. Kathy Buto, V...
Machine learning for gene expression-based prediction of individual drug response for cancer patien
by williams
Nicolas . Borisov. . 1,. *, Victor . Tkachev. . ...
Using Marion County Coroner Data to Inform the Prevention of Opiate Overdose Fatalities
by angelina
Aaron C. Willis, PhD(c), AM, LSW. Acknowledgements...
Session 8: Study Start-up: Part 2
by gabriella
Derita: . dbran@uthsc.edu. Margaret: . mlynn@ut...
Gilead-initiated or Gilead-supported Abstracts Published at EACS 2023
by hailey
Abstracts selected by Gilead Medical Affairs Germa...
Figure from a MMIC-related publication
by esther
Biacore T200 Components. Examples:. -Amine chemist...
KENYA Dr. Evelyn Muthoni Karanja
by vivian
AIDS 2018. WHO ARV guidelines satellite. 23 July 2...
Optimizing HIV treatment
by anderson
Professor Francois Venter. Ezintsha, University of...
Table 12.1 Medicare Part D parameters for defined standard benefit, 2009 & 2014
by molly
2016 Annual Data Report, Vol . 2, ESRD. , . Ch. ....
Writing and Holding an IND- IIT Development
by osullivan
Week 3- Proposing and Conducting a Clinical Trial....
HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP HMPWG
by danya
GUIDANCE ON MODULE 3 OF THE HOMEOPATHIC MEDICINAL ...
Load More...